The groundbreaking treatment is one of six gene therapies cleared since 2017 that have transformed the outlook for disorders once considered hopeless and also renewed questions about how the health care system can afford such breathtakingly expensive medicines.
By Deena Beasley (Reuters) - Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their .
Drugmakers are launching new medicines at record-high prices this year, a Reuters analysis has found, highlighting their pricing power even as Congress moves to cut the $500 billion-plus annual bill